Ursprung des Netzwerks ersten Grades von Clifford Birge
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA.
16
| Extinct | Pharmaceuticals: Major | 16 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Clifford Birge
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Director of Finance/CFO Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
| KINIKSA PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Director/Board Member | |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Pharmaceuticals: Major | Director/Board Member | |
| BEIGENE, LTD. | Pharmaceuticals: Major | Director/Board Member | |
Hinge Bio, Inc.
 Hinge Bio, Inc. BiotechnologyHealth Technology Hinge Bio, Inc. is a holding company, which engages in the development of specific and multi-specific antibodies. The company is headquartered in Burlingame, CA. | Biotechnology | Director/Board Member | |
| KURA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
Benevolent Healthcare Foundation
 Benevolent Healthcare Foundation Medical/Nursing ServicesHealth Services Benevolent Healthcare Foundation provides medical supplies and services. The company was founded by James W. Jackson in 1987 and is headquartered in Centennial, CO. | Medical/Nursing Services | Director/Board Member | |
| Janus Henderson Global Life Sciences Fund | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Mossrock Capital LLC
 Mossrock Capital LLC Investment ManagersFinance Mossrock Capital LLC (Mossrock Capital) is a venture capital/private equity firm founded in 2007. The firm is headquartered in Englewood, Colorado. | Investment Managers | President | |
Craig Hospital
 Craig Hospital Hospital/Nursing ManagementHealth Services Craig Hospital is a center for specialty rehabilitation and research for people with spinal cord injury and traumatic brain injury. The firm provides a system of inpatient and outpatient medical care, rehabilitation, neurosurgical rehabilitative care and long-term follow up services. The company was founded in 1907 and is headquartered in Denver, CO. | Hospital/Nursing Management | Director/Board Member | |
Project C.U.R.E., Inc.
 Project C.U.R.E., Inc. Medical/Nursing ServicesHealth Services Project C.U.R.E., Inc. is a non-profit drug rehabilitation program located in Dayton, OH. The non-profit company's mission is to reduce and minimize substance abuse by providing professional rehabilitative and support services to people with substance abuse problems in Montgomery County. The company offers a full range of innovative treatment and behavior options to empower individuals who are opioid dependent to live a lifestyle free of addiction. All employees, students, and volunteers are committed to a belief in the dignity and worth of the individual human being and maintain integrity with respect to their duties as they come in contact with clients, other service providers, and the public at large. | Medical/Nursing Services | Chairman | |
Janus Henderson Investors US LLC
 Janus Henderson Investors US LLC Investment ManagersFinance Janus Henderson Investors US LLC (JHIUS) is a registered investment advisor and mutual fund manager headquartered in Denver, Colorado. The firm was founded in 1969 and formerly known as Janus Capital Management LLC. They are a subsidiary of Janus Henderson US (Holdings) Inc., which is owned by Janus Henderson Group plc (NYSE: JHG, LON: 0RPW) in Great Britain. JHIUS provides investment management services, as an investment adviser or sub-adviser, to pooled investment vehicles. | Investment Managers | Portfolio Manager-Equities | |
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Biotechnology | Chairman | |
Velocity Pharmaceutical Development LLC
 Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | Drugstore Chains | Director/Board Member | |
| ALZA CORPORATION | Pharmaceuticals: Major | Chairman | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Director/Board Member | |
| AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| TONIX PHARMACEUTICALS HOLDING CORP. | Pharmaceuticals: Major | Director/Board Member | |
Bullet Biotechnology, Inc.
 Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Biotechnology | Director/Board Member | |
| ALZA Pharmaceuticals | Corporate Officer/Principal | ||
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| XOMA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member | |
| Boston University | College/University | Undergraduate Degree | |
| University of California | College/University | Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree | |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Chief Tech/Sci/R&D Officer | ||
LumiCyte, Inc.
 LumiCyte, Inc. BiotechnologyHealth Technology LumiCyte, Inc. provides biotechnology services and offers biochips and information products to the pharmaceutical and biotechnology companies. The company also designs, manufactures, and distributes STS MALDI chips for mass spectrometry analysis of proteins and peptides. Its products are used for the identification and analysis of markers involved in disease processes. The company was founded by T. William Hutchens in 2003 and is headquartered in Fremont, CA | Biotechnology | Corporate Officer/Principal | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 49 |
| Cayman Islands | 2 |
| Israel | 2 |
Sektoral
| Health Technology | 31 |
| Finance | 7 |
| Consumer Services | 6 |
| Health Services | 4 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 77 |
| Corporate Officer/Principal | 53 |
| Chairman | 22 |
| Chief Tech/Sci/R&D Officer | 20 |
| Independent Dir/Board Member | 20 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Arie Belldegrun | 42 |
| Samuel Saks | 28 |
| Russell Ellison | 20 |
| Thomas Malley | 17 |
| William F. Daly | 15 |
| Arturo Molina | 13 |
| Richard Benton Phillips | 13 |
| Charles R. Eyler | 11 |
| Christopher Haqq | 10 |
| Alan Auerbach | 9 |
| Steven Rosenberg | 6 |
| Harold J. Meyers | 6 |
| Thomas W. Griffin | 6 |
| Michael M. Meyers | 5 |
| Patrick Verheyen | 4 |
- Börse
- Insiders
- Clifford Birge
- Unternehmensverbindungen
